ERIE vs. RYAN, TRV, ALL, ACGL, WRB, MKL, CINF, FNF, CNA, and ORI
Should you be buying Erie Indemnity stock or one of its competitors? The main competitors of Erie Indemnity include Ryan Specialty (RYAN), Travelers Companies (TRV), Allstate (ALL), Arch Capital Group (ACGL), W.R. Berkley (WRB), Markel Group (MKL), Cincinnati Financial (CINF), Fidelity National Financial (FNF), CNA Financial (CNA), and Old Republic International (ORI).
Erie Indemnity vs. Its Competitors
Erie Indemnity (NASDAQ:ERIE) and Ryan Specialty (NYSE:RYAN) are both large-cap finance companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, analyst recommendations, valuation, profitability, risk, institutional ownership and media sentiment.
33.7% of Erie Indemnity shares are held by institutional investors. Comparatively, 84.8% of Ryan Specialty shares are held by institutional investors. 45.8% of Erie Indemnity shares are held by company insiders. Comparatively, 52.2% of Ryan Specialty shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
In the previous week, Ryan Specialty had 2 more articles in the media than Erie Indemnity. MarketBeat recorded 7 mentions for Ryan Specialty and 5 mentions for Erie Indemnity. Ryan Specialty's average media sentiment score of 0.72 beat Erie Indemnity's score of -0.17 indicating that Ryan Specialty is being referred to more favorably in the news media.
Erie Indemnity pays an annual dividend of $5.46 per share and has a dividend yield of 1.6%. Ryan Specialty pays an annual dividend of $0.48 per share and has a dividend yield of 0.7%. Erie Indemnity pays out 46.5% of its earnings in the form of a dividend. Ryan Specialty pays out 141.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Erie Indemnity has raised its dividend for 36 consecutive years and Ryan Specialty has raised its dividend for 1 consecutive years. Erie Indemnity is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Erie Indemnity has a net margin of 15.73% compared to Ryan Specialty's net margin of 6.97%. Ryan Specialty's return on equity of 47.70% beat Erie Indemnity's return on equity.
Erie Indemnity has higher revenue and earnings than Ryan Specialty. Erie Indemnity is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.
Erie Indemnity has a beta of 0.35, suggesting that its stock price is 65% less volatile than the S&P 500. Comparatively, Ryan Specialty has a beta of 0.66, suggesting that its stock price is 34% less volatile than the S&P 500.
Ryan Specialty has a consensus target price of $75.58, suggesting a potential upside of 14.21%. Given Ryan Specialty's stronger consensus rating and higher probable upside, analysts plainly believe Ryan Specialty is more favorable than Erie Indemnity.
Summary
Ryan Specialty beats Erie Indemnity on 11 of the 19 factors compared between the two stocks.
Get Erie Indemnity News Delivered to You Automatically
Sign up to receive the latest news and ratings for ERIE and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ERIE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Erie Indemnity Competitors List
Related Companies and Tools
This page (NASDAQ:ERIE) was last updated on 7/5/2025 by MarketBeat.com Staff
